AI 의료기기 시장 규모, 점유율, 동향 분석 : 제공 내용별, 치료 분야별, 기술별, 최종사용자별, 지역별 - 세계 기회 분석과 산업 예측

The global AI in Medical Devices Market is expected to witness substantial growth during the forecast period, driven by the increasing integration of artificial intelligence (AI) into medical technologies, rising demand for precision diagnostics, growing adoption of intelligent clinical decision support systems, and expanding digital transformation across healthcare. AI-powered medical devices leverage advanced technologies such as machine learning, deep learning, computer vision, natural language processing (NLP), and generative AI to improve diagnostic accuracy, automate clinical workflows, enable predictive analytics, and enhance patient outcomes across a broad range of healthcare applications.

AI-enabled medical devices are transforming healthcare delivery by supporting clinicians in disease detection, image interpretation, patient monitoring, surgical planning, treatment optimization, and personalized medicine. These devices are increasingly integrated into diagnostic imaging systems, wearable health devices, robotic surgical platforms, smart monitoring equipment, and therapeutic systems, enabling healthcare providers to make faster, more informed clinical decisions while improving operational efficiency. Advances in cloud computing, edge AI, high-performance computing, and healthcare interoperability are further strengthening the capabilities of AI-enabled medical devices across hospitals, diagnostic centers, ambulatory care settings, and home healthcare environments.

The increasing prevalence of chronic diseases, aging populations, growing demand for minimally invasive procedures, rising healthcare data volumes, and shortage of healthcare professionals are among the major factors supporting market growth. Healthcare providers are increasingly investing in AI-enabled medical devices to improve diagnostic consistency, reduce clinician workload, enhance workflow automation, and support value-based healthcare delivery. At the same time, regulatory agencies are progressively establishing frameworks for the evaluation and approval of AI-powered medical devices, encouraging broader commercialization and clinical adoption.

This report provides a comprehensive assessment of the global AI in medical devices market by analyzing current industry dynamics, technological advancements, competitive developments, and future growth opportunities across major components, technologies, device types, end users, and geographic regions. The study evaluates key market trends, regulatory developments, investment activities, adoption patterns, strategic partnerships, and competitive strategies adopted by industry participants to provide actionable insights for stakeholders operating across the AI-enabled medical device ecosystem.

Market Dynamics

The AI in medical devices market is expanding due to the increasing need for intelligent clinical decision support, growing adoption of precision medicine, rising demand for workflow automation, and increasing integration of AI into diagnostic and therapeutic medical devices. Healthcare providers are increasingly deploying AI-powered solutions to improve disease detection, enhance image interpretation, optimize patient monitoring, automate repetitive clinical tasks, and improve healthcare delivery efficiency. The growing availability of healthcare data and advances in AI algorithms are further accelerating market adoption across multiple clinical specialties.

Technological innovation remains a key factor shaping market growth. Modern AI-enabled medical devices increasingly incorporate deep learning, machine learning, computer vision, natural language processing, predictive analytics, edge computing, and cloud-based AI platforms. These technologies enable automated medical image analysis, anomaly detection, risk prediction, personalized treatment recommendations, remote patient monitoring, and intelligent clinical workflow management. Integration with electronic health records (EHRs), hospital information systems (HIS), picture archiving and communication systems (PACS), laboratory information systems (LIS), and telehealth platforms further enhances the clinical value of AI-powered medical devices by enabling seamless data exchange and coordinated patient care.

Despite strong growth opportunities, several factors continue to influence market adoption. Regulatory complexities associated with AI-based medical devices, concerns regarding algorithm transparency, data privacy and cybersecurity risks, interoperability challenges, high implementation costs, and limited availability of high-quality clinical datasets remain important barriers. Healthcare organizations must also address issues related to clinical validation, physician trust, explainable AI, reimbursement policies, and continuous monitoring of adaptive AI systems.

The market nevertheless presents significant opportunities for medical device manufacturers, AI technology providers, and healthcare organizations. Increasing regulatory approvals for AI-enabled medical devices, growing investments in digital health, rising adoption of robotic-assisted procedures, expansion of remote patient monitoring, and continuous advances in generative AI are expected to support sustained market growth. Strategic collaborations among medical device companies, healthcare providers, cloud technology companies, academic institutions, and AI developers are accelerating innovation and commercialization across the market.

At the same time, market participants must continue addressing evolving regulatory requirements, cybersecurity standards, algorithm validation, interoperability challenges, ethical AI considerations, and clinician acceptance to maintain long-term competitiveness in the rapidly evolving AI in medical devices market.

Segment Analysis

The report provides an extensive analysis of the AI in medical devices market across component, technology, device type, end user, and geography, enabling stakeholders to identify high-growth segments and emerging investment opportunities.

Based on component, the market is analyzed across software, hardware, and services. Software solutions account for the largest share of the market owing to increasing adoption of AI-powered diagnostic algorithms, clinical decision support platforms, medical image analysis software, workflow automation solutions, and predictive analytics applications. AI software enables healthcare providers to process large volumes of clinical data, improve diagnostic accuracy, automate routine clinical tasks, and support personalized treatment planning. Continuous advancements in machine learning, deep learning, computer vision, and generative AI are further driving innovation across software platforms.

Hardware components are witnessing increasing demand due to the growing integration of AI processors, intelligent sensors, edge computing capabilities, and high-performance computing technologies into medical devices. AI-enabled imaging systems, patient monitoring devices, robotic surgical platforms, and wearable medical devices increasingly incorporate advanced hardware to support real-time data processing and intelligent decision-making at the point of care.

Services are expected to register strong growth during the forecast period due to increasing demand for AI implementation, system integration, algorithm validation, cloud deployment, consulting, maintenance, training, and regulatory support services. Healthcare organizations increasingly require specialized expertise to successfully deploy AI-enabled medical devices, integrate them into existing clinical workflows, and ensure compliance with evolving regulatory standards.

Based on technology, the market is evaluated across machine learning, deep learning, computer vision, natural language processing (NLP), generative AI, and other AI technologies.

Machine learning and deep learning technologies continue to represent the largest share of the market due to their widespread application in disease detection, predictive analytics, clinical decision support, medical image interpretation, and patient risk assessment. These technologies enable AI-enabled medical devices to continuously improve diagnostic performance by learning from large clinical datasets.

Computer vision is witnessing significant growth owing to increasing adoption in radiology, pathology, ophthalmology, endoscopy, dermatology, and surgical navigation applications. Computer vision algorithms enable automated analysis of medical images, improve diagnostic consistency, and support clinicians in identifying subtle abnormalities that may otherwise be difficult to detect.

Natural language processing (NLP) is increasingly being integrated into AI-enabled medical devices to extract valuable clinical insights from unstructured medical records, physician notes, pathology reports, and patient documentation. Generative AI is emerging as a transformative technology capable of supporting clinical documentation, intelligent decision support, personalized treatment planning, simulation, and workflow optimization, creating new opportunities across the healthcare ecosystem.

Based on device type, the market is segmented into diagnostic & imaging devices, patient monitoring devices, surgical & robotic devices, wearable medical devices, therapeutic devices, and other AI-enabled medical devices.

Diagnostic & imaging devices account for a significant share of the market due to increasing adoption of AI-assisted radiology, pathology, cardiology, oncology, ophthalmology, and other imaging applications. AI-powered diagnostic devices improve image interpretation, accelerate diagnosis, reduce clinician workload, and support early disease detection.

Patient monitoring devices are expected to witness substantial growth during the forecast period owing to increasing adoption of remote patient monitoring, connected healthcare solutions, wearable technologies, and AI-driven predictive monitoring systems. AI enables continuous analysis of physiological data, early detection of clinical deterioration, and personalized patient management.

Surgical & robotic devices are gaining importance with increasing adoption of robotic-assisted surgery and AI-powered surgical planning systems. AI technologies improve surgical precision, optimize procedural planning, support intraoperative decision-making, and enhance patient outcomes. Wearable medical devices and therapeutic devices are also experiencing strong growth due to increasing demand for continuous health monitoring, personalized therapy, and home-based healthcare solutions.

Based on end user, the market is segmented into hospitals & healthcare providers, ambulatory surgical centers, diagnostic centers, home healthcare, and other end users.

Hospitals and healthcare providers continue to represent the largest end-user segment due to increasing investments in digital healthcare transformation, adoption of advanced medical technologies, availability of specialized clinical infrastructure, and growing focus on improving diagnostic accuracy and operational efficiency.

Diagnostic centers are increasingly implementing AI-enabled diagnostic systems to improve workflow efficiency, reduce reporting turnaround times, and enhance diagnostic consistency. Ambulatory surgical centers are adopting AI-assisted surgical technologies to improve procedural outcomes and operational productivity, while home healthcare is expected to witness the fastest growth owing to increasing adoption of AI-enabled wearable devices, remote monitoring solutions, and personalized home-based care.

Regional Analysis

The report offers a comprehensive assessment of market performance across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Each regional analysis considers healthcare infrastructure, AI adoption, medical device innovation, regulatory landscape, digital health investments, and competitive intensity to provide a holistic understanding of regional growth dynamics.

North America currently represents the largest share of the global AI in medical devices market owing to its advanced healthcare infrastructure, strong presence of leading medical device manufacturers and AI technology companies, increasing regulatory approvals for AI-enabled medical devices, high healthcare expenditure, and growing adoption of precision medicine. Continuous investments in healthcare innovation and digital transformation continue to strengthen regional market leadership.

Europe demonstrates strong market growth supported by increasing adoption of AI technologies in healthcare, expanding medical device innovation, growing government support for digital health initiatives, and increasing investments in healthcare research. The presence of established medical device manufacturers and favorable regulatory developments are expected to further accelerate market adoption across the region.

Asia-Pacific is expected to register the fastest growth during the forecast period due to expanding healthcare infrastructure, increasing healthcare expenditure, growing adoption of artificial intelligence technologies, rising demand for advanced medical devices, and supportive government initiatives promoting healthcare digitalization across China, India, Japan, South Korea, Australia, and Southeast Asian countries. The region's large patient population and increasing burden of chronic diseases create substantial opportunities for AI-enabled medical device manufacturers.

Latin America and the Middle East & Africa are also expected to present attractive growth opportunities as healthcare systems continue to modernize, digital health adoption increases, and investments in advanced medical technologies expand. Growing awareness regarding AI-enabled healthcare solutions, improving healthcare infrastructure, and increasing focus on improving healthcare accessibility and efficiency are expected to support market growth across these emerging regions.

Competitive Landscape

The report presents a detailed evaluation of the competitive landscape, offering valuable insights into the strategic positioning of major industry participants. It examines company portfolios, business strategies, technological capabilities, product launches, regulatory approvals, mergers and acquisitions, partnerships, collaborations, geographic expansion initiatives, research and development investments, and other significant corporate developments shaping the competitive environment.

Company benchmarking enables stakeholders to compare market participants based on their AI-enabled medical device portfolios, artificial intelligence capabilities, clinical validation expertise, software and hardware integration capabilities, regulatory approvals, geographic presence, innovation capabilities, and competitive strengths. The report also evaluates the evolving competitive intensity resulting from continuous advancements in machine learning, deep learning, computer vision, natural language processing, generative AI, edge computing, cloud computing, and healthcare interoperability technologies, along with increasing investments in intelligent medical devices and digital healthcare transformation.

As healthcare organizations increasingly prioritize precision diagnostics, workflow automation, predictive healthcare, personalized treatment, and data-driven clinical decision-making, market participants are focusing on developing AI-powered diagnostic systems, intelligent imaging platforms, AI-assisted surgical technologies, smart patient monitoring devices, connected wearable medical devices, and integrated clinical decision support solutions. These technologies enable healthcare providers to improve diagnostic accuracy, optimize clinical workflows, reduce operational burdens, enhance patient outcomes, and expand access to advanced healthcare services.

Continuous innovation aimed at improving algorithm performance, clinical accuracy, explainability, cybersecurity, interoperability, scalability, and integration with electronic health records (EHRs), picture archiving and communication systems (PACS), hospital information systems (HIS), laboratory information systems (LIS), cloud platforms, and remote patient monitoring ecosystems is expected to strengthen competitive differentiation across the market. Leading companies are also strengthening their global market presence through strategic collaborations with healthcare providers, research institutions, medical device manufacturers, cloud technology companies, and AI developers, while investing in research and development, regulatory approvals, product innovation, and next-generation AI-enabled healthcare technologies.

Key companies profiled in the report include GE HealthCare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Medtronic plc, Abbott Laboratories, Canon Medical Systems Corporation, Fujifilm Holdings Corporation, NVIDIA Corporation, Microsoft Corporation, and Tempus AI, Inc.

How This Report Helps

• Provides reliable market size estimates and long-term growth forecasts.
• Evaluates major market drivers, restraints, opportunities, challenges, and emerging industry trends.
• Identifies high-growth component, technology, device type, end-user, and regional segments.
• Assesses evolving technology adoption and innovation across the AI-enabled medical device ecosystem.
• Benchmarks leading companies based on their product portfolios, strategic initiatives, technological capabilities, and competitive positioning.
• Supports business expansion, investment planning, partnership evaluation, AI implementation strategies, digital healthcare transformation initiatives, and product development activities.
• Delivers actionable insights for medical device manufacturers, healthcare providers, AI technology companies, healthcare IT vendors, investors, consultants, and other industry stakeholders.

Key Questions Answered

• What is the current size of the global AI in medical devices market, and what is its projected growth through 2036?
• Which factors are driving, restraining, and influencing market growth?
• What opportunities and challenges are expected to shape the industry during the forecast period?
• Which component, technology, device type, end-user, and regional segments are expected to witness the strongest growth?
• Which regions are expected to offer the most attractive business opportunities?
• Who are the leading companies operating in the market, and how are they strengthening their competitive positions?
• What recent technological developments, product launches, regulatory approvals, partnerships, acquisitions, and strategic initiatives are influencing the competitive landscape?
• How can stakeholders leverage market intelligence from this report to support strategic planning, investment decisions, AI adoption strategies, intelligent medical device development, digital healthcare transformation, and product innovation initiatives?

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Scope
• 1.3. Currency and Pricing

2. Research Methodology

• 2.1. Research Process
• 2.2. Data Collection & Sources
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Market Sizing & Forecasting
  • 2.3.1. Bottom-up Approach
  • 2.3.2. Top-down Approach
• 2.4. Data Triangulation & Validation
• 2.5. Assumptions & Limitations

3. Executive Summary

• 3.1. Market Overview
• 3.2. Segmental Analysis
• 3.3. Geographic Outlook
• 3.4. Competitive Insights

4. Market Insights

• 4.1. Introduction
• 4.2. Market Dynamics
  • 4.2.1. Drivers
    • 4.2.1.1. Increasing Prevalence of Chronic Diseases and Demand for Early Diagnosis
    • 4.2.1.2. Global Shortage of Healthcare Professionals and Need for Efficiency
  • 4.2.2. Restraints
    • 4.2.2.1. Data Privacy Concerns and Cybersecurity Risks
    • 4.2.2.2. High Initial Implementation and Training Costs
  • 4.2.3. Opportunities
    • 4.2.3.1. Growth of Remote Patient Monitoring and AI-Enabled Wearables
    • 4.2.3.2. Expansion of Healthcare Infrastructure in Emerging Markets
  • 4.2.4. Challenges
    • 4.2.4.1. Evolving Regulatory Frameworks for AI/ML-Based SaMD
    • 4.2.4.2. Interoperability and Integration with Existing Clinical Workflows
• 4.3. Porter's Five Forces Analysis
• 4.4. Regulatory Landscape
• 4.5. Value Chain Analysis

5. Global AI Medical Devices Market Assessment, by Offering

• 5.1. Introduction
• 5.2. Software (SaMD)
• 5.3. Hardware (AI-Integrated Devices)
• 5.4. Services

6. Global AI Medical Devices Market Assessment, by Therapeutic Area

• 6.1. Introduction
• 6.2. Radiology
• 6.3. Cardiology
• 6.4. Neurology
• 6.5. Oncology
• 6.6. Others

7. Global AI Medical Devices Market Assessment, by Technology

• 7.1. Introduction
• 7.2. Machine Learning
• 7.3. Natural Language Processing
• 7.4. Computer Vision

8. Global AI Medical Devices Market Assessment, by End User

• 8.1. Introduction
• 8.2. Hospitals & Clinics
• 8.3. Diagnostic Centers
• 8.4. Pharmaceutical & Biotechnology Companies
• 8.5. Academic & Research Institutions

9. Global AI Medical Devices Market Assessment, by Geography

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. UK
  • 9.3.3. France
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Rest of Europe
• 9.4. Asia-Pacific
  • 9.4.1. China
  • 9.4.2. India
  • 9.4.3. Japan
  • 9.4.4. Singapore
  • 9.4.5. Australia
  • 9.4.6. South Korea
  • 9.4.7. Rest of Asia-Pacific
• 9.5. Latin America
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America
• 9.6. Middle East & Africa
  • 9.6.1. UAE
  • 9.6.2. Saudi Arabia
  • 9.6.3. South Africa
  • 9.6.4. Rest of MEA

10. Competitive Landscape

• 10.1. Introduction
• 10.2. Market Share Analysis
• 10.3. Competitive Benchmarking
• 10.4. Strategic Developments
  • 10.4.1. Product Launches & Enhancements
  • 10.4.2. Partnerships & Collaborations
  • 10.4.3. Mergers & Acquisitions

11. Company Profiles (Active Manufacturers Only)

• 11.1. GE HealthCare Technologies Inc.
• 11.2. Siemens Healthineers AG
• 11.3. Koninklijke Philips N.V.
• 11.4. Medtronic plc
• 11.5. Abbott Laboratories
• 11.6. Johnson & Johnson
• 11.7. Stryker Corporation
• 11.8. Boston Scientific Corporation
• 11.9. Canon Medical Systems Corporation
• 11.10. Fujifilm Holdings Corporation
• 11.11. Hologic, Inc.
• 11.12. Terumo Corporation
• 11.13. Smith & Nephew plc
• 11.14. Roche Holding AG
• 11.15. NVIDIA Corporation
• 11.16. Aidoc Medical Ltd.
• 11.17. Viz.ai, Inc.
• 11.18. Arterys Inc. (Tempus)
• 11.19. Zebra Medical Vision (Nanox)
• 11.20. Butterfly Network, Inc.

12. Appendix